AnaptysBio Correlations

ANAB Stock  USD 38.48  0.95  2.53%   
The current 90-days correlation between AnaptysBio and Deciphera Pharmaceuticals LLC is 0.05 (i.e., Significant diversification). The correlation of AnaptysBio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

AnaptysBio Correlation With Market

Weak diversification

The correlation between AnaptysBio and DJI is 0.32 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding AnaptysBio and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AnaptysBio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade AnaptysBio Stock refer to our How to Trade AnaptysBio Stock guide.

Moving together with AnaptysBio Stock

  0.87JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.73PFE Pfizer Inc Fiscal Year End 4th of February 2025 PairCorr
  0.8SNY Sanofi ADRPairCorr
  0.66XGN Exagen IncPairCorr
  0.63BIAFW BioAffinity TechnologiesPairCorr
  0.7REGN Regeneron PharmaceuticalsPairCorr
  0.89APGE Apogee Therapeutics, Upward RallyPairCorr
  0.75SERA Sera Prognostics Downward RallyPairCorr
  0.71AVTR AvantorPairCorr
  0.61SMMT Summit Therapeutics PLC Buyout TrendPairCorr
  0.61SNDL SNDL IncPairCorr
  0.74BDSX BiodesixPairCorr
  0.64SYRE Spyre Therapeutics Symbol ChangePairCorr

Moving against AnaptysBio Stock

  0.83MBIO Mustang BioPairCorr
  0.82LPCN LipocinePairCorr
  0.74RANI Rani TherapeuticsPairCorr
  0.7DYAI Dyadic InternationalPairCorr
  0.7ONCT Oncternal TherapeuticsPairCorr
  0.68PTN Palatin Technologies Earnings Call This WeekPairCorr
  0.66DNA Ginkgo Bioworks Holdings TrendingPairCorr
  0.64MRK Merck Company Sell-off TrendPairCorr
  0.63MOLN Molecular PartnersPairCorr
  0.43BNR Burning Rock BiotechPairCorr
  0.39REVBW Revelation BiosciencesPairCorr
  0.34ERNA Eterna TherapeuticsPairCorr
  0.72EDAP EDAP TMS SAPairCorr
  0.53MCK McKesson Sell-off TrendPairCorr
  0.49DRIO DarioHealth CorpPairCorr
  0.49AGL agilon healthPairCorr
  0.48TOVX Theriva BiologicsPairCorr
  0.41AWH Aspira Womens HealthPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
RYTMCRNX
CTMXKURA
KURARYTM
KURACRNX
CTMXRYTM
CTMXCRNX
  
High negative correlations   
RYTMDCPH
CRNXDCPH
KURADCPH
CTMXDCPH

Risk-Adjusted Indicators

There is a big difference between AnaptysBio Stock performing well and AnaptysBio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze AnaptysBio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

AnaptysBio Corporate Management

Martin DahlSenior ResearchProfile
Monique SilvaSenior AffairsProfile
James MDAdvisorProfile
Beth MuellerSenior ResourcesProfile
Priya RainaSenior OperationsProfile
Eric LoumeauGeneral CounselProfile
FAAD MBAChief OfficerProfile